ORAGENICS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
ORAGENICS, INC. (OGEN) reported Cash and Cash Equivalents, Period Increase (Decrease) of $2.08 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-11-14
- ORAGENICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$3.43M, a 134.73% decline year-over-year.
- ORAGENICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$3.63M.
- ORAGENICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $9.14M.
- ORAGENICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $6.40M, a 97.27% increase year-over-year.
- ORAGENICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $14.04M, a 573.32% increase from fiscal 2017.
- ORAGENICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $2.09M.
- ORAGENICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$948.58K.
- ORAGENICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$5.45M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | -$3.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$7.06M derived: sum of 2 quarters · filed 2019-11-14 | $2.08M 10-Q · filed 2019-11-14 | $8.48M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2019-06-30 | -$3.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $5.51M 10-Q · filed 2019-08-14 | $11.91M derived: sum of 3 quarters · filed 2019-08-14 | $21.78M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2019-03-31 | $9.14M 10-Q · filed 2019-05-13 | $15.54M derived: sum of 2 quarters · filed 2019-05-13 | $25.41M derived: sum of 3 quarters · filed 2019-11-14 | $24.59M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $16.27M derived: sum of 2 quarters · filed 2019-11-14 | $15.45M derived: sum of 3 quarters · filed 2019-11-14 | $14.04M 10-K · filed 2019-03-29 | ||||
| 2018-09-30 | $9.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $9.05M derived: sum of 2 quarters · filed 2019-11-14 | $7.65M 10-Q · filed 2019-11-14 | $10.89M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$817.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$2.23M 10-Q · filed 2019-08-14 | $1.02M derived: sum of 3 quarters · filed 2019-08-14 | $1.85M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | -$1.41M 10-Q · filed 2019-05-13 | $1.83M derived: sum of 2 quarters · filed 2019-05-13 | $2.67M derived: sum of 3 quarters · filed 2019-05-13 | $2.58M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $4.08M derived: sum of 2 quarters · filed 2019-03-29 | $3.99M derived: sum of 3 quarters · filed 2019-03-29 | $2.09M 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | $834.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $748.28K derived: sum of 2 quarters · filed 2018-11-13 | -$1.16M 10-Q · filed 2018-11-13 | -$2.18M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$86.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$1.99M 10-Q · filed 2018-08-13 | -$3.02M derived: sum of 3 quarters · filed 2018-08-13 | -$3.21M derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | -$1.91M 10-Q · filed 2018-05-15 | -$2.93M derived: sum of 2 quarters · filed 2018-05-15 | -$3.13M derived: sum of 3 quarters · filed 2018-05-15 | -$1.20M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$1.22M derived: sum of 2 quarters · filed 2018-02-16 | $705.16K derived: sum of 3 quarters · filed 2018-02-16 | -$948.58K 10-K · filed 2018-02-16 | ||||
| 2016-09-30 | -$196.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $1.73M derived: sum of 2 quarters · filed 2017-10-31 | $76.04K 10-Q · filed 2017-10-31 | -$1.63M derived: sum of 4 quarters · filed 2017-10-31 | ||||
| 2016-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $272.34K 10-Q · filed 2017-08-14 | -$1.44M derived: sum of 3 quarters · filed 2017-08-14 | -$2.82M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | -$1.65M 10-Q · filed 2017-05-15 | -$1.72M 10-Q · filed 2016-05-16 | -$3.36M derived: sum of 2 quarters · filed 2017-05-15 | -$4.74M derived: sum of 3 quarters · filed 2017-05-15 | -$5.71M derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$3.09M derived: sum of 2 quarters · filed 2017-02-27 | -$4.06M derived: sum of 3 quarters · filed 2017-02-27 | -$5.45M 10-K · filed 2017-02-27 | -$5.37M 10-K · filed 2016-03-30 | |||
| 2015-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$2.35M derived: sum of 2 quarters · filed 2016-11-14 | -$3.74M 10-Q · filed 2016-11-14 | -$3.71M 10-Q · filed 2015-11-06 | -$5.06M derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | -$966.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$2.36M 10-Q · filed 2016-08-15 | -$2.41M 10-Q · filed 2015-08-07 | -$3.68M derived: sum of 3 quarters · filed 2016-08-15 | -$4.81M derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | -$1.40M 10-Q · filed 2016-05-16 | -$2.71M derived: sum of 2 quarters · filed 2016-05-16 | -$3.85M derived: sum of 3 quarters · filed 2016-05-16 | -$5.59M derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$2.45M derived: sum of 2 quarters · filed 2016-03-30 | -$4.19M derived: sum of 3 quarters · filed 2016-03-30 | -$5.83M 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | -$1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$2.87M derived: sum of 2 quarters · filed 2015-11-06 | -$4.51M 10-Q · filed 2015-11-06 | $3.50M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2014-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$3.38M 10-Q · filed 2015-08-07 | $4.63M derived: sum of 3 quarters · filed 2015-08-07 | $6.53M derived: sum of 4 quarters · filed 2015-08-07 | ||||
| 2014-03-31 | -$1.64M 10-Q · filed 2015-05-08 | $6.37M derived: sum of 2 quarters · filed 2015-05-08 | $8.27M derived: sum of 3 quarters · filed 2015-05-08 | $6.29M derived: sum of 4 quarters · filed 2015-05-08 | ||||
| 2013-12-31 | $8.01M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $9.91M derived: sum of 2 quarters · filed 2015-02-27 | $7.93M derived: sum of 3 quarters · filed 2015-02-27 | $6.35M 10-K · filed 2015-02-27 | ||||
| 2013-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | -$82.44K derived: sum of 2 quarters · filed 2014-11-03 | -$1.66M 10-Q · filed 2014-11-03 | -$3.49M derived: sum of 4 quarters · filed 2014-11-03 | ||||
| 2013-06-30 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$3.56M 10-Q · filed 2014-08-07 | -$5.39M derived: sum of 3 quarters · filed 2014-08-07 | $5.24M derived: sum of 4 quarters · filed 2014-08-07 | ||||
| 2013-03-31 | -$1.58M 10-Q · filed 2014-05-09 | -$3.41M derived: sum of 2 quarters · filed 2014-05-09 | $7.22M derived: sum of 3 quarters · filed 2014-05-09 | $7.38M derived: sum of 4 quarters · filed 2014-05-09 | ||||
| 2012-12-31 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $8.80M derived: sum of 2 quarters · filed 2014-02-28 | $8.96M derived: sum of 3 quarters · filed 2014-02-28 | $9.75M 10-K · filed 2014-02-28 | ||||
| 2012-09-30 | $10.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25 | $10.79M derived: sum of 2 quarters · filed 2013-10-25 | $11.59M 10-Q · filed 2013-10-25 | $11.76M derived: sum of 4 quarters · filed 2013-10-25 | ||||
| 2012-06-30 | $162.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $958.75K 10-Q · filed 2013-08-12 | $1.13M derived: sum of 3 quarters · filed 2013-08-12 | $1.13M derived: sum of 4 quarters · filed 2013-08-12 | ||||
| 2012-03-31 | $796.21K 10-Q · filed 2013-05-15 | $967.94K derived: sum of 2 quarters · filed 2013-05-15 | $967.94K derived: sum of 3 quarters · filed 2013-05-15 | $911.51K derived: sum of 4 quarters · filed 2013-05-15 | ||||
| 2011-12-31 | $171.74K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | $171.74K derived: sum of 2 quarters · filed 2013-03-26 | $115.31K derived: sum of 3 quarters · filed 2013-03-26 | $39.64K 10-K · filed 2013-03-26 | ||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$56.43K derived: sum of 2 quarters · filed 2012-11-14 | -$132.10K 10-Q · filed 2012-11-14 | -$505.21K derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | -$56.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | -$132.10K 10-Q · filed 2012-08-10 | -$505.21K derived: sum of 3 quarters · filed 2012-08-10 | -$216.75K derived: sum of 4 quarters · filed 2012-08-10 | ||||
| 2011-03-31 | -$75.67K 10-Q · filed 2012-05-15 | -$448.78K derived: sum of 2 quarters · filed 2012-05-15 | -$160.32K derived: sum of 3 quarters · filed 2012-05-15 | |||||
| 2010-12-31 | -$373.11K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$84.65K derived: sum of 2 quarters · filed 2012-04-16 | -$169.49K 10-K · filed 2012-04-16 | |||||
| 2010-09-30 | $288.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $203.62K 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$84.84K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |